Discovering a Reversible Male Contraceptive Agent Derived from Lonidamine.

Gong, Shengnan; Zhu, Shiyao; Zhou, Peng; Cheng, C Yan; Li, Wenqing; Yao, Weiwei; Sun, Fei

Gong, Shengnan; Zhu, Shiyao; Zhou, Peng; Cheng, C Yan; Li, Wenqing; Yao, Weiwei; Sun, Fei.

Afiliação

Gong S; Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong, Jiangsu 226019, P. R. China.
Zhu S; Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong, Jiangsu 226019, P. R. China.
Zhou P; Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong, Jiangsu 226019, P. R. China.
Cheng CY; Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong, Jiangsu 226019, P. R. China.
Li W; Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong, Jiangsu 226019, P. R. China.
Yao W; Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong, Jiangsu 226019, P. R. China.
Sun F; Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong, Jiangsu 226019, P. R. China.

ACS Omega ; 8(20): 18245-18254, 2023 May 23.

Article em En | MEDLINE | ID: mdl-37251173

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Omega Ano de publicação: 2023 Tipo de documento: Article